KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Receivables (2016 - 2026)

National Health Investors filings provide 18 years of Receivables readings, the most recent being $6.6 million for Q1 2026.

  • On a quarterly basis, Receivables fell 5.17% to $6.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $6.6 million, a 5.17% decrease, with the full-year FY2025 number at $6.8 million, down 58.34% from a year prior.
  • Receivables hit $6.6 million in Q1 2026 for National Health Investors, down from $6.8 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $16.2 million in Q4 2024 to a low of $6.6 million in Q1 2023.
  • Median Receivables over the past 5 years was $7.0 million (2022), compared with a mean of $9.2 million.
  • Biggest five-year swings in Receivables: soared 138.64% in 2024 and later tumbled 58.34% in 2025.
  • National Health Investors' Receivables stood at $6.9 million in 2022, then grew by 1.45% to $7.0 million in 2023, then soared by 131.64% to $16.2 million in 2024, then tumbled by 58.34% to $6.8 million in 2025, then dropped by 1.72% to $6.6 million in 2026.
  • The last three reported values for Receivables were $6.6 million (Q1 2026), $6.8 million (Q4 2025), and $6.8 million (Q3 2025) per Business Quant data.